Incannex Healthcare (IXHL) Current Leases (2022 - 2026)
Incannex Healthcare (IXHL) posted quarterly Current Leases of $72000.0 for Q1 2026, down 61.29% year-on-year from $186000.0 in Q1 2025, and down 34.55% on a QoQ basis from $110000.0 in Q4 2025.
Incannex Healthcare (IXHL) Current Leases (2022 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Current Leases for 5 consecutive years, with $72000.0 the latest figure, recorded in Q1 2026.
- Quarterly Current Leases fell 61.29% year-over-year to $72000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72000.0 (down 61.29% YoY) and the FY2025 annual result came in at $184000.0, up 12.88% from the prior year.
- Current Leases retreated to $72000.0 in Q1 2026 per IXHL's latest filing, from $110000.0 in the prior quarter.
- Over the last five years, Current Leases for IXHL reached as high as $190000.0 in Q3 2024 and fell as low as $50468.0 in Q4 2022.
- A 5-year average of $143455.7 and a median of $162000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases jumped 234.87% — and 2026, when it tumbled 61.29%.
- Year by year, Current Leases stood at $50468.0 in 2022, then soared by 234.87% to $169000.0 in 2023, then gained by 4.73% to $177000.0 in 2024, then tumbled by 37.85% to $110000.0 in 2025, then tumbled by 34.55% to $72000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $72000.0, $110000.0, and $146000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 146,000.00 |
| Jun 30, 2025 | 184,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 177,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 169,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Dec 31, 2022 | 50,468.00 |